Market Research Reports and Industry Reports

Australia Immuno Chemistry Market Outlook to 2024

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Australia Immuno Chemistry Market Outlook to 2024

Summary

GlobalDatas new report, Australia Immuno Chemistry Market Outlook to 2024, provides key market data on the Australia Immuno Chemistry market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Complement Deficiency Tests, Diabetes Assays, Disease Specific Immunochemistry, Endocrinology Tests, IgE Allergy Blood Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC and Vitamins Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Immuno Chemistry market segments - Complement Deficiency Tests, Diabetes Assays, Disease Specific Immunochemistry, Endocrinology Tests, IgE Allergy Blood Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC and Vitamins Tests.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
- 2017 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the Australia Immuno Chemistry market.
- Key players covered include Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Abbott Laboratories and Thermo Fisher Scientific Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.

2
1.List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.What Is This Report About? 6
2.2 Immuno Chemistry Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 8
3 Immuno Chemistry Market, Australia 12
3.Immuno Chemistry Market, Australia, Revenue ($m), 2010-2017 12
3.2 Immuno Chemistry Market, Australia, Revenue ($m), 2017-2024 14
3.2.Complement Deficiency Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 16
3.2.2 Diabetes Assays Market, Australia, Revenue ($m), by Segment, 2010-2017 18
3.2.3 Disease Specific Immunochemistry Market, Australia, Revenue ($m), by Segment, 2010-2017 20
3.2.4 Endocrinology Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 22
3.2.5 IgE Allergy Blood Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 24
3.2.6 Immunochemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2010-2017 26
3.2.7 Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2010-2017 28
3.2.8 Vitamins Tests Market, Australia, Revenue ($m), by Segment, 2010-2017 30
3.2.9 Complement Deficiency Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 32
3.2.10 Diabetes Assays Market, Australia, Revenue ($m), by Segment, 2017-2024 34
3.2.1Disease Specific Immunochemistry Market, Australia, Revenue ($m), by Segment, 2017-2024 36
3.2.12 Endocrinology Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 38
3.2.13 IgE Allergy Blood Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 40
3.2.14 Immunochemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2017-2024 42
3.2.15 Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), by Segment, 2017-2024 44
3.2.16 Vitamins Tests Market, Australia, Revenue ($m), by Segment, 2017-2024 46
3.3 Immuno Chemistry Market, Australia, Volume (Units), 2010-2017 48
3.4 Immuno Chemistry Market, Australia, Volume (Units), 2017-2024 50
3.4.Complement Deficiency Tests Market, Australia, Volume (Units), by Segment, 2010-2017 52
3.4.2 Diabetes Assays Market, Australia, Volume (Units), by Segment, 2010-2017 54
3.4.3 Disease Specific Immunochemistry Market, Australia, Volume (Units), by Segment, 2010-2017 56
3.4.4 Endocrinology Tests Market, Australia, Volume (Units), by Segment, 2010-2017 58
3.4.5 IgE Allergy Blood Tests Market, Australia, Volume (Units), by Segment, 2010-2017 60
3.4.6 Immunochemistry Analyzers Market, Australia, Volume (Units), by Segment, 2010-2017 62
3.4.7 Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), by Segment, 2010-2017 64
3.4.8 Vitamins Tests Market, Australia, Volume (Units), by Segment, 2010-2017 66
3.4.9 Complement Deficiency Tests Market, Australia, Volume (Units), by Segment, 2017-2024 68
3.4.10 Diabetes Assays Market, Australia, Volume (Units), by Segment, 2017-2024 70
3.4.1Disease Specific Immunochemistry Market, Australia, Volume (Units), by Segment, 2017-2024 72
3.4.12 Endocrinology Tests Market, Australia, Volume (Units), by Segment, 2017-2024 74
3.4.13 IgE Allergy Blood Tests Market, Australia, Volume (Units), by Segment, 2017-2024 76
3.4.14 Immunochemistry Analyzers Market, Australia, Volume (Units), by Segment, 2017-2024 78
3.4.15 Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), by Segment, 2017-2024 80
3.4.16 Vitamins Tests Market, Australia, Volume (Units), by Segment, 2017-2024 82
3.5 Immuno Chemistry Market, Australia, Average Price ($), 2010-2024 84
3.6 Immuno Chemistry Market, Australia, Distribution Share by Revenue ($m), 2017 88
3.7 Immuno Chemistry Market, Australia, Company Share by Revenue ($m), 2017 89
4 Overview of Key Companies in Australia, Immuno Chemistry Market 91
4.F. Hoffmann-La Roche Ltd 91
4.1.Company Overview 91
4.2 Siemens Healthcare GmbH 91
4.2.Company Overview 91
4.3 Beckman Coulter Inc 91
4.3.Company Overview 91
4.4 Thermo Fisher Scientific Inc 92
4.4.Company Overview 92
4.5 Abbott Laboratories 92
4.5.Company Overview 92
4.6 Bio-Rad Laboratories Inc 92
4.6.Company Overview 92
4.7 bioMerieux SA 92
4.7.Company Overview 92
5 Immuno Chemistry Market Pipeline Products 93
6 Financial Deals Landscape 96
6.Debt Offerings 96
6.1.CSL Raises USD250 Million in Private Placement of 3.17% Debt Securities Due 2027 96
6.1.2 CSL Raises USD200 Million in Private Placement of 3.32% Debt Securities Due 2029 97
6.1.3 CSL Raises USD150 Million in Private Placement of 3.47% Debt Securities Due 2032 98
6.1.4 CSL Raises USD100 Million in Private Placement of 3.77% Debt Securities Due 2037 99
6.2 Equity Offerings 100
6.2.Biotron to Raise USD1.2 Million in Rights Offering of Shares 100
7 Recent Developments 102
7.Financial Announcements 102
7.1.Aug 16, 2017: CSL announces Full Year Result 2017 102
7.1.2 Feb 15, 2017: CSL Announces Half Year Result 2017 103
7.1.3 Jan 19, 2017: CSL reports FY2017 profit upgrade 104
7.2 Legal And Regulatory 104
7.2.Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility 104
7.3 Other Significant Developments 105
7.3.Sep 11, 2017: Pharming Announces Conclusion of FDA End of Phase 2 Interactions on RUCONEST for Prophylaxis of HAE 105
7.3.2 Aug 02, 2017: New Australian studies reveal that both infants and GP office patients are exposed to considerably more antibiotics than needed 106
7.3.3 Dec 09, 2016: Adheriums Smartinhaler Technology Chosen for Major Asthma Initiative 106
7.4 Product News 108
7.4.Aug 31, 2017: New screening test could help identify pregnancy complications 108
7.4.2 Jun 09, 2017: Gold Standard Technique For Cancer Research Revealed By Global Study 108
8 Appendix 110
8.Research Methodology 111
8.1.Coverage 111
8.1.2 Secondary Research 111
8.1.3 Primary Research 112
8.1.4 Market Modeling and Forecasting 113
8.1.5 Company Share Analysis 114
8.1.6 Distribution Share Analysis 115
8.1.7 Benchmarking 115
8.2 GlobalData Consulting 115
8.3 Contact Us 116
8.4 Disclaimer 116

List Of Tables

1.1 List of Tables
Table 1: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 13
Table 2: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 15
Table 3: Complement Deficiency Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 17
Table 4: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 19
Table 5: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 21
Table 6: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 23
Table 7: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 25
Table 8: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 27
Table 9: Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 29
Table 10: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 31
Table 11: Complement Deficiency Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 33
Table 12: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 35
Table 13: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 37
Table 14: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 39
Table 15: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 41
Table 16: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 43
Table 17: Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 45
Table 18: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 47
Table 19: Immuno Chemistry Market, Australia, Volume (Units), Historic, 2010-2017 49
Table 20: Immuno Chemistry Market, Australia, Volume (Units), Forecast, 2017-2024 51
Table 21: Complement Deficiency Tests Market, Australia, Volume (Units), Historic, 2010-2017 53
Table 22: Diabetes Assays Market, Australia, Volume (Units), Historic, 2010-2017 55
Table 23: Disease Specific Immunochemistry Market, Australia, Volume (Units), Historic, 2010-2017 57
Table 24: Endocrinology Tests Market, Australia, Volume (Units), Historic, 2010-2017 59
Table 25: IgE Allergy Blood Tests Market, Australia, Volume (Units), Historic, 2010-2017 61
Table 26: Immunochemistry Analyzers Market, Australia, Volume (Units), Historic, 2010-2017 63
Table 27: Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 65
Table 28: Vitamins Tests Market, Australia, Volume (Units), Historic, 2010-2017 67
Table 29: Complement Deficiency Tests Market, Australia, Volume (Units), Forecast, 2017-2024 69
Table 30: Diabetes Assays Market, Australia, Volume (Units), Forecast, 2017-2024 71
Table 31: Disease Specific Immunochemistry Market, Australia, Volume (Units), Forecast, 2017-2024 73
Table 32: Endocrinology Tests Market, Australia, Volume (Units), Forecast, 2017-2024 75
Table 33: IgE Allergy Blood Tests Market, Australia, Volume (Units), Forecast, 2017-2024 77
Table 34: Immunochemistry Analyzers Market, Australia, Volume (Units), Forecast, 2017-2024 79
Table 35: Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 81
Table 36: Vitamins Tests Market, Australia, Volume (Units), Forecast, 2017-2024 83
Table 37: Immuno Chemistry Market, Australia, Average Price ($) Historic, 2010-2017 84
Table 38: Immuno Chemistry Market, Australia, Average Price ($), Forecast, 2017-2024 86
Table 39: Immuno Chemistry Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 88
Table 40: Immuno Chemistry Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 90
Table 41: Immuno Chemistry Market Pipeline Products 93
Table 42: CSL Raises USD250 Million in Private Placement of 3.17% Debt Securities Due 2027 96
Table 43: CSL Raises USD200 Million in Private Placement of 3.32% Debt Securities Due 2029 97
Table 44: CSL Raises USD150 Million in Private Placement of 3.47% Debt Securities Due 2032 98
Table 45: CSL Raises USD100 Million in Private Placement of 3.77% Debt Securities Due 2037 99
Table 46: Biotron to Raise USD1.2 Million in Rights Offering of Shares 100
Table 47: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 113

Caltex Australia Ltd (CTX) - Oil & Gas - Deals and Alliances Profile

Caltex Australia Limited (Caltex) is a transport fuel supplier and convenience retailer. It is the parent company of Caltex group. The company purchases, refines, distributes and markets petroleum products. It

USD 250View Report

Australia Iron Ore Market Research Report 2017

The Australia Iron Ore market is valued at 34395.47 million USD in 2016 and is expected to reach 78203.78 million USD by the end of 2022, growing at a CAGR

USD 4000View Report

Canada In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Canada In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology CultureGlobalDatas new report, Canada In Vitro

USD 5995View Report

Brazil In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Brazil In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology CultureGlobalDatas new report, Brazil In Vitro

USD 5995View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 4995
  • Site Licence    USD 9990
  • Enterprise Wide Licence    USD 14985
$ 4995

Reports Details

Published Date : Nov 2017
No. of Pages :116
Country :Australia
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube